Clinical TrialsSearch results
Number of results: 290
Other
- Randomized Phase III Trial of Conventional Paclitaxel and Carboplatin Versus Dose Dense weekly Paclitaxel and Carboplatin in Patients With Newly Diagnosed Stage II-IV Mullerian Carcinoma (Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer)
- Patients with stageII-IV Mullerian Carcinoma (Ovarian Epithelial,Primary Peritoneal,or Fallopian Tube Cancer)
- Japanese Gynecologic Oncology Group
- 2005-09-15
Other
- Randomized Phase III Trial Comparing surgery-alone to UFT+PSK in Stage II Rectal Cancer
- Rectal cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01
Other
- Randomized phase III study of FOLFOX plus bevacizumab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer
- metastatic colorectal cancer
- West Japan Oncology Group
- 2008-09-26
Other
- Randomized phase III study of CPT-11 versus Weekly Paclitaxel for unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum.
- unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum
- West Japan Oncology Group
- 2008-07-15
Other
- Randomized phase II trial of gemcitabine(GEM) and carboplatin (CBDCA) with or without Dexamethasone(Dex) in untreated non-small cell lung cancer (NSCLC).
- Non small cell lung cancer
- Kyoto Thoracic Oncology Research Group (KTORG)
- 2007-01-01
Other
- Randomized phase II study of mFOLFOX6 versus TS-1/CPT-11 in patients with advanced/recurrent colorectal cancer
- Patients with advanced and/or recurrent colorectal cancer
- OGSG
- 2007-08-09
Other
- Randomized phase II study of CPT-11 versus TXL versus each combination chemotherapy with TS-1 against progressed/relapsed gastric cancer after TS-1 or TS-1/ platinum compounds chemotherapy (OGSG 0701)
- progressed/relapsed gastric cancer after TS-1 or TS-1/ platinum compounds chemotherapy
- Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)
- 2007-04-19
Other
- Randomized phase II study comparing Gemcitabine versus TS-1 for advanced bile duct cancer
- Advanced bile duct cancer
- Osaka International Cancer Institute Department of Hepatobiliary and pancreatic Oncology
- 2008-12-22
Other
- randomized phase 2 study of Docetaxel+CBDCA versus weekly Paclitaxel+CBDCA
- ovarian cancer
- Osaka Medical College
- 2005-10-01
Other
- Randomized Parallel Group Phase II Clinical Study of Sorafenib/Interferon Combination Therapy and Sunitinib Monotherapy for Advanced Renal Cell Carcinoma
- Advanced renal cell carcinoma
- Osaka Urological Oncology Research Group
- 2009-05-21